Preservation of sexual function with Optilume—a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia

• Published in: Journal of sexual medicine Vol. 22; no. 3; pp. 446 - 453
• Main Authors: Copelan, Olivia, Moss, Jared, Freedman, Sheldon, Coutinho, Karl, Elterman, Dean, Marotte, Jeffrey, Padron, Osvaldo, Shore, Neal, Spier, Jeffrey, Kaminetsky, Jed, Mazzarella, Brian, Te, Alexis, Kaplan, Steven A, McVary, Kevin T
• Format: Journal Article
• Language: English
• Published: Netherlands 08.04.2025
• Subjects: Aged; Dilatation - instrumentation; Dilatation - methods; Ejaculation; Erectile Dysfunction - etiology; Erectile Dysfunction - prevention & control; Humans; Lower Urinary Tract Symptoms - etiology; Lower Urinary Tract Symptoms - therapy; Male; Middle Aged; Prostatic Hyperplasia - complications; Semen Analysis; Sexual Dysfunction, Physiological - prevention & control; Surveys and Questionnaires; Treatment Outcome; benign prostatic hyperplasia (BPH); ejaculatory function; erectile function; sexual function; randomized controlled trial (RCT); lower urinary tract symptoms (LUTS); prostate

The Optilume benign prostatic hyperplasia (BPH) catheter system is a novel minimally invasive paclitaxel-coated dilation system that has demonstrated substantial and durable results in urinary flow and symptoms. We now assess the impact of Optilume BPH procedure on sexual function. Prior published r...